-+ 0.00%
-+ 0.00%
-+ 0.00%

CASI Pharmaceuticals Reports Positive Phase 1 Results for CID-103 in Immune Thrombocytopenia

路透·12/08/2025 14:00:50

登錄查看新聞詳情